Browse Biopharmaceutics topic

Health aspects subtopic

Articles 1-40 out of 40 article(s) Title Author Type Date Words EXCELIMMUNE AWARDED NIH SBIR GRANT FOR ANTIBODY THERAPY. Dec 1, 2009 471 BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antibodies. Nov 13, 2009 510 PIKAMAB to Customize Cancer Antibody Therapies. Nov 12, 2009 839 (SCI) TURKISH RESEARCHERS SUCCEED IN PRODUCING THERAPEUTIC PROTEIN FROM TRANSGENIC RATS. Aug 26, 2009 248 Defense Advanced Research Projects Agency Awards $12 Million to Fraunhofer CMB and iBioPharma for Accelerated Manufacture of Biopharmaceuticals. Mar 11, 2009 748 Research and Markets: Analytical Tool - Cancer Therapeutic Antibodies. Feb 23, 2009 319 Flamel Technologies Announces Merck Serono's Exercise of Option to License Medusa Technology for Development of an Extended-Release Formulation of a Therapeutic Protein. Feb 17, 2009 626 Progenics Selects Subcutaneous Form of PRO 140, a Novel HIV Antibody Therapy, for Further Development. Feb 10, 2009 1867 Morphotek[R], Inc. Announces Research Agreement with The University of Pennsylvania to Develop Oncology Therapeutic Antibody Candidates. Dec 22, 2008 632 United States: Morphotek[R], Inc. Receives Additional $1.6M in Funding from The U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons. Nov 21, 2008 239 Morphotek[R], Inc. Receives Additional $1.6M in Funding from The U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons. Nov 20, 2008 566 Delivering Therapeutic Proteins - An Analysis of the Special Formulations and Delivery Strategies Required for Complex Therapeutic Substances. Oct 3, 2008 561 Competitor Analysis: Biogenerics & Therapeutic Proteins. Jun 25, 2008 647 United States: Morphotek[R], Inc. Receives $1.7M in Funding from the U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons. Jun 24, 2008 249 Morphotek(R), Inc. Receives $1.7M in Funding from the U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons. Jun 23, 2008 694 MHC Biologics Sets Sights on the Next Generation of Monoclonal Antibody Therapies. Company overview Jun 16, 2008 700 PanGenetics Raises 23 Million Euro in Series C Financing to Fund Clinical Advancement of Its Therapeutic Antibody Programs. Mar 5, 2008 1166 Progenics Initiates Phase 2 Clinical Trials for PRO 140, a Novel HIV Antibody Therapy. Jan 15, 2008 1444 Merck Serono and Flamel to Collaborate on an Extended Release Formulation for Therapeutic Proteins. Dec 20, 2007 855 Plexera Bioscience Announces Agreement with Leading Therapeutic Antibody Company. Nov 13, 2007 509 Morphotek Receives $2.7M in Funding from the National Institute of Allergy and Infectious Diseases to Develop Therapeutic Antibodies Against Biowarfare Agents. Oct 3, 2007 757 Morphotek Receives $2.3M in Funding from the U.S. Department of Defense to Develop Therapeutic Antibodies Against Biowarfare Agents. Sep 19, 2007 645 Dyax Corp. and Bayer Schering Pharma AG Enter Into a Collaboration Agreement for Discovery of Therapeutic Antibodies. Sep 5, 2007 790 Morphotek Signs Development and Clinical Supply Agreement with CMC Biopharmaceuticals A/S for Therapeutic Antibody to Treat Melanoma. May 21, 2007 524 Dyax Corp. and Glenmark Enter Into Funded Research Agreement for Discovery of Therapeutic Antibodies. Mar 12, 2007 1143 Dyax Corp. Announces Funded Research Agreement with Trubion Pharmaceuticals Inc. for Discovery of Therapeutic Proteins. Oct 5, 2006 682 Affitech to Play Key Role in Major EU Embryonal Tumor Pipeline Project; Proprietary Discovery Platforms to Be Utilized to Identify Fully Human Therapeutic Antibody Candidates. Sep 12, 2006 460 GlycoFi and Dartmouth Report Full Humanization of Yeast Glycosylation Pathway in Science; Availability of Engineered Yeast Strains Could Eliminate the Need for Mammalian Cell Culture and Offer Opportunities for Improving Therapeutic Proteins. Sep 7, 2006 475 PROTHERA AWARDED $2.8 MIL NIH GRANTS FOR SEPSIS/ANTHRQX. Aug 1, 2006 808 Celera Genomics and Medarex Establish Therapeutic Antibody Collaboration in Cancer; Collaboration Combines Celera's Protein Discoveries with Medarex's Expertise in Developing Fully Human Antibody Therapeutics. Jun 22, 2006 1304 Alfacell announces new research collaboration to develop next-generation targeted therapies for cancer. Jun 1, 2006 526 XOMA and Schering-Plough Establish Collaboration for Therapeutic Antibody Discovery and Development. May 23, 2006 576 BioInvent and Immusol to Collaborate on Antibody Therapeutic for Macular Degeneration. Apr 3, 2006 613 Compugen Announces In-Silico Protein Discovery from ''Junk DNA''; Findings Published in Proceedings of the National Academy of Sciences; Methodology has Enabled Discovery of Novel Therapeutic Protein Candidates. Feb 14, 2006 660 MethylGene Unveils HDAC Anti-Fungal Program. Dec 16, 2005 674 Amgen to Acquire Abgenix for $22.50 Per Share; Provides Amgen With Full Ownership of Panitumumab and Eliminates a Denosumab Royalty. Dec 14, 2005 2297 Progenics Pharmaceuticals Initiates Clinical Trial of Viral-Entry Inhibitor PRO 140 in HIV-Infected Patients; Monoclonal Antibody Designed to Block HIV Infection of Immune System Cells. Dec 1, 2005 1461 Talecris Biotherapeutics' Manufacturing Processes Safeguard Against Avian Bird Flu; Processes Assure Inactivation of Enveloped Viruses Like H5N1, Preventing Potential Transmission Through Talecris' Therapeutic Plasma Proteins. Nov 9, 2005 663 Agensys and Merck Announce Agreement to Co-Develop and Commercialize a Novel Antibody for Cancer Therapy. Oct 17, 2005 975 Cell Genesys reports potential breakthrough in antibody production technology. Apr 1, 2005 591